The latest report published by Market Research Future (MRFR) projects that the global Cardiopulmonary Exercise Testing Market Share will exhibit a CAGR of 5.80% during the review period. Cardiopulmonary exercise testing is conducted to assess the health of cardiopulmonary organs of a person. It allows physicians to accurately measure the exercise capacity and anticipated outcome in patient with heart ailments or any other cardiac condition. In addition, such tests allow evaluation of responses from integrative exercise for patients having cardiovascular and pulmonary issues. As per Global Cardiopulmonary Exercise Testing Market Trends Analysis, the Global Market based companies will face certain challenges during the forecast period 2020 to 2027.

The patient pool for cardiovascular disorders has been expanding at an alarming rate. Sedentary lifestyle and rich diet are usually cited for development of cardiovascular issues. The factors mentioned above are in common practice all around the world. The number of people with cardiovascular disease has continued to rise. Centers for Disease Control and Prevention states that the About 610,000 people die of heart disease in the United States every year–that’s 1 in every 4 deaths. The level of awareness regarding the risk of heart diseases is rising, which is partly driving the popularity of cardiopulmonary exercise testing.

Cardiopulmonary exercise testing has undergone tremendous technological advancement over the years, making it more accurate and efficient. The focus remains on improving the accuracy of cardiopulmonary exercise testing. R&D efforts are made towards making testing equipment portable and in the process making testing procedures much more affordable. Introduction of devices to improve patient care and development of system that facilitate relaxed testing environment, helping reduce patient anxiety has taken cardiopulmonary exercise testing towards perfection.

Global Cardiopulmonary Exercise Testing Market: Segmental Analysis

MRFR’s report includes a comprehensive segmental analysis of the market based on products and end-user. On the basis of product, the market has been segmented into cardiopulmonary exercise testing (CPET) systems, echocardiogram, pulse oximeters, stress blood pressure monitors, invasive cardiopulmonary exercise testing ,single-photon emission computed tomography (SPECT), and others. Of these, the cardiopulmonary exercise testing systems segment is expected to post a health growth rate over in the years to come. The segment currently accounts for the largest share of the market. This is attributed to the increasing incidence of ischemia. Moreover, cardiopulmonary exercise testing systems are a common medical equipment and continue to witness high demand in the healthcare sector.  

On the basis of end-user, the global cardiopulmonary exercise testing market is segmented into hospitals and clinics, diagnostic centers, ambulatory centers, and others. The hospitals and clinics segment is currently holds the top position. The segment is projected to reach a market valuation of over USD 1100 Mn by the year 2023, reflecting an impressive growth rate. Growing need for diagnosis and treatment of heart diseases and coronary diseases is supporting the growth of the segment.

Global Cardiopulmonary Exercise Testing Market: Regional Analysis

The market has been covered across major regions such as Europe, North America, South America, the Middle East & Africa (MEA) and Asia Pacific (APAC). North America and South America collectively accounted for the largest market in 2017 and the trend is likely to continue in 2018 and beyond. Presence of a large patient population and availability of cutting-edge medical technology put the Americas, in particular North America at an advantageous position in the global cardiopulmonary exercise testing market. In addition, widespread awareness about advantages of early diagnostics is creating growth opportunities for market in North America. Meanwhile, Europe represent the second largest market for cardiopulmonary exercise testing. Factors such as high healthcare expenditure and availability of medical welfare schemes are having positive impact on the regions market.

Global Cardiopulmonary Exercise Testing Market: Competitive Landscape

MGC Diagnostics Corporation, GE Healthcare, COSMED srl, Hill-Rom Holdings, Inc., Cardinal Health, Vyaire Medical, Inc., Halma plc., Masimo Corporation, Schiller AG, Koninklijke Philips N.V., and NIHON KOHDEN CORPORATION are some of notable companies that are currently operating in the global cardiopulmonary exercise testing market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York, New York 10013,

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com